143 filings
8-K
AEON
AEON Biopharma Inc. - Ordinary Shares
16 May 24
Departure of Directors or Certain Officers
4:27pm
8-K
AEON
AEON Biopharma Inc. - Ordinary Shares
14 May 24
AEON Biopharma Reports First Quarter 2024 Financial Results
4:07pm
DEFA14A
AEON
AEON Biopharma Inc. - Ordinary Shares
14 May 24
Additional proxy soliciting materials
9:14am
8-K
lvvy55tpz87mk
3 May 24
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
4:27pm
8-K
s0aqmwp6vt0e2yj7qe
3 May 24
AEON Biopharma Announces Preliminary Top-Line Results from Phase 2 Interim Analysis of ABP-450 in the Preventive Treatment of Chronic Migraine
7:01am
ARS
1qki d6g2vdp8
29 Apr 24
Annual report to shareholders
4:28pm
25-NSE
7232bm34o24r4tp
29 Apr 24
Exchange delisting
4:18pm
8-K
atadimldif pwv
17 Apr 24
Entry into a Material Definitive Agreement
4:06pm
8-K
0rto0l5ivjo
15 Apr 24
Regulation FD Disclosure
4:16pm
S-8
fji2p43j52nnzo gekm
1 Apr 24
Registration of securities for employees
5:27pm
8-K
tix ystafc6
29 Mar 24
AEON Biopharma Announces Redemption of Public Warrants
4:16pm
8-K
rudq1e
29 Mar 24
AEON Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results
3:46pm